ABSTRACT : The present study investigated an ethanol extract of Chaenomeles sinensis fruit (CSF) for possible neuroprotective effects on neurotoxicity induced by amyloid β protein (Aβ) (25-35) in cultured rat cortical neurons and also for antidementia activity in mice. 
INTRODUCTION
Chaenomeles sinensis (Thouin) Koehne fruit (family: Rosaceae) (CSF) has been widely used as a traditional Chinese medicine to treat throat disease. It is known as an antitussive, antiflatulent and diuretic agent in folk medicine. CSF is rich in dietary fibre, organic acids and bioactive pentacyclic triterpene acids such as oleanolic acid and ursolic acid and large amounts of bioactive phenolic acids and vitamin C (Hamauzu et al., 2008; Ros et al., 2004; Thomas et al., 2000; Zhang et al., 2007) . Flavonoid is one of the main phytochemical constituents in CSF and has been proven effective in preventing free radical-caused oxidative damage (Hamauzu et al., 2005; Zhou et al., 2007; Hu et al., 2008) . Antibacterial, antiviral, antihemolytic and antipruritic activities have been reported as pharmacological activities of CSF (Osawa et al., 1997; Lee et al., 2002; Oku et al., 2003; Sawai et al., 2008) . Anti-inflammatory effect of CSF was inferred based on the fact that it inhibited histamine release from rat mast cells and inhibited activation of hyaluronidase (Osawa et al., 1999 (Osawa et al., , 2001 ).
Alzheimer's disease (AD) is characterized by neuronal loss and extracellular senile plaque, whose major constituent is amyloid β protein (Aβ), a 39-43 amino acid peptide derived from amyloid precursor protein (Ivins et al., 1999) . Both in vitro and in vivo studies have reported the toxic effects of Aβ or Aβ peptide fragments suggesting an important role of Aβ in the pathogenesis of AD (Demuro et al., 2010) . The mechanisms underlying Aβ-neurotoxicity are complex but may involve Nmethyl-D -aspartate (NMDA) receptor, a glutamate receptor subtype, modulation induced by glutamate release, sustained elevations of intracellular Ca 2+ concentration ([Ca 2+ ] i ), and oxidative stresses (Ekinci et al., 2000; Gray and Patel, 1995; Ueda et al., 1997 ).
An experimental model that mimics the progression of AD was developed using an intracerebroventricular (i.c.v.) injection of Aβ in mice (Van Dam and De Deyn, 2006) . I.c.v. Injection of in mice resulted in learning and memory deficits that were accompanied by a decrease of choline-acetyltransferase and an increase of cholinesterase activity, suggesting that accumulation of Aβ disrupted cholinergic activity and caused the cognitive impairments of AD (Maurice et al., 1996; Ruan et al., 2009; Tohda et al., 2004) . The deposition of Aβ in the pathogenesis of AD is invariably associated with oxidative stress and inflammatory responses. (Butterfield and Lauderback, 2002; Butterfield et al., 2007) . Antioxidants such as α-tocopherol protect against Aβ-induced cytotoxicity in vitro as well as against development of learning and memory deficits in vivo (Yamada et al., 1999) . Additionally, anti-inflammatory agents such as indomethacin reportedly slow the progression of AD (Gasparini et al., 2004) . We hypothesized that CSF might protect neurons against neurodegeneration in AD due to its antioxidant and antiinflammatory activities. The purpose of our study was to determine whether an ethanol extract of CSF have a protective effect against Aβ (25-35)-induced memory deficits in mice and Aβ (25-35)-induced neuronal damage in cultured rat cortical neurons.
MATERIALS AND METHODS

Plant materials and extraction
The dried and sliced CSF was purchased from Daegu Oriental Pharm Co. at Daegu, Korea and identified by one of the authors (Dr. Kyung-sik Song). A voucher specimen (KNUNPC-CSF-10-001) was deposited at Natural Products Chemistry Laboratory, Kyungpook National University, Daegu, Korea. CSF (2 ㎏) was refluxed with 20 L of 95% ethanol for 3 h and the extract was filtered through filter paper (Advantec MFS, CA, USA). The filtrate was concentrated to dryness under reduced pressure with a rotary evaporator to yield an ethanol extract (250 g), which was then stored at room temperature until required.
Experimental animals
Pregnant Sprague-Dawley (SD) rats for primary neuronal culture and male ICR mice for the passive avoidance test were supplied by Daehan BioLink Co., Ltd. (Chungbuk, Korea) and housed in an environmentally controlled room at 22 ± 2℃, with a relative humidity of 55 ± 5%, a 12-h light/dark cycle, and food and water ad libitum. The procedures involving experimental animals complied with the animal care guidelines of the National Institutes of Health and the animal ethics committee of Chungbuk National University.
3. Induction of neurotoxicity in primary cultures of rat cerebral cortical neurons Primary cortical neuron cultures were prepared using embryonic day 15 to 16 SD rat fetuses, as previously described . Neurotoxicity experiments were performed on neurons after 3-4 days in culture. Cultured neurons were treated with 10 µM Aβ (25-35) (Bachem, Bubendorf, Switzerland) in serum-free Dulbecco's modified Eagle's medium (DMEM) (Sigma) at 37℃ for 36 h (unless otherwise indicated) to produce neurotoxicity. An Aβ (25-35) stock solution of 2 mM was prepared in sterile distilled water, stored at −20℃, and incubated for more than 2 days at 37℃ to aggregate before use. CSF was dissolved in dimethylsulfoxide (DMSO) at concentrations of 50 ㎎/㎖ and further diluted in experimental buffers. The final concentration of DMSO was ≤ 0.1%, which did not affect cell viability. For each experiment, CSF was applied 15 min prior to treatment with 10 µM Aβ (25) (26) (27) (28) (29) (30) (31) (32) (33) (34) (35) . It was also present in the medium during Aβ (25-35) incubation.
Measurements of Aβ (25-35)-induced neuronal death and intracellular biochemical changes
A 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT; Sigma) assay and Hoechst 33342 (Molecular Probes, Eugene, OR, USA) staining were performed to measure neuronal death 36 h after exposure of cultured neurons to 10 µM Aβ (25-35), as described previously 
. Changes in [Ca
2+
] i were measured with Fluo-4 AM (Molecular Probes), a calcium-sensitive fluorescent dye, using a laser scanning confocal microscope (LSM 510, Carl Zeiss, Oberkochen,
Germany) with a 488-㎚ excitation argon laser and 515-㎚ longpass emission filters . The microfluorescence of 2',7'-dichlorofluorescein, the fluorescent product of 2',7'-dichlorodihydrofluorescein diacetate (H 2 DCF-DA; Molecular Probes), and a laser scanning confocal microscope (MRC1024ES, Bio-Rad, Maylands, UK) with 488-㎚ excitation and 510-㎚ emission filters were used to monitor the generation of reactive oxygen species (ROS) in neurons treated with 10 µM Aβ (25-35) for 36 h .
Examination of learning and memory and measurement of brain cholinesterase activity
Induction of memory impairment in mice was performed by i.c.v. injection of the aggregated form of Aβ (25-35) (15 nmol), as previously described . CSF (10, 25, and 50 ㎎/㎏) suspended in distilled water was orally administered 30 min before the injection of Aβ (25-35) and further administered daily for 7 days. Memory acquisition was evaluated using stepthrough passive avoidance apparatus (Gemini Avoidance System, San Diego, CA, USA) according to the method previously described . At 30 min after administration of CSF on day 7 of i.c.v. injection of Aβ (25-35), mice were trained on step-through passive avoidance task. Retention trial was given 24 h after the training trial. After the retention trial of passive avoidance test, cholinesterase activity of mice whole brain was determined by the method of Hestrin (1949) with a slight modification as previously described (Cho et al., 2009) .
Statistical analysis
Data are expressed as mean ± S.E.M.. Student's t-test was used for comparisons between two groups, and one-way analysis of variance (ANOVA) followed by Tukey's test was used for multiple comparisons. P < 0.05 was considered significant.
RESULTS
Effect of CSF on Aβ (25-35)-induced neuronal cell death
Based on our previous result (Lee et al., 2005) , an Aβ (25-35) concentration of 10 µM was used for determining Aβ (25-35)-induced neuronal cell damage in the present study. When cortical neurons were exposed to 10 µM Aβ (25-35) for 36 h, absorbance in the MTT assay was 63.6 ± 2.6% of that of the untreated controls ( Fig. 1) , indicating that Aβ (25-35) caused neuronal cell death. In cultures treated with CSF (0.1, 1 and 10 ㎍/㎖), the Aβ (25-35)-induced neuronal death was significantly reduced (absorbance, 7.9 ± 1.9%, 81.1 ± 3.1%, and 85.2 ± 2.5% of control, respectively) ( Fig. 1) .
Hoechst 33342 staining was used to detect condensed or fragmented DNA, which is indicative of Aβ (25-35)-induced neuronal apoptotic death. Treatment of neurons with 10 µM Aβ (25-35) produced apoptosis of 32.7 ± 1.9% of the total population of cultured cortical neurons, as compared with 8.4 ± 1.2% of apoptotic neurons in control cultures. The addition of CSF (0.1, 1 and 10 ㎍/㎖) significantly decreased the Aβ (25-35)-induced apoptotic cell death, showing 23.6 ± 1.9%, 21.1 ± 1.6%, and 15.9 ± 1.8% of all neurons, respectively (Fig. 2) . ## P < 0.01 vs control (Student's t-test); **P < 0.01 vs 10 µM Aβ (25-35) (Tukey's test).
Effect of CSF on
increase followed by a gradual increase in response to treatment with 10 µM Aβ (25-35) with intermittent fluctuations over 10 min (Fig. 3) . In contrast, pretreatment with CSF (0.1 and 10 ㎍/㎖) showed a significant inhibition of the increase of [Ca 
Effect of CSF on Aβ (25-35)-induced ROS generation
The involvement of oxidative stress in Aβ neurotoxicity was investigated by measurement of ROS accumulation after the exposure of the neurons to Aβ (25-35) for 36 h. In H 2 DCF-DAloaded cultured neurons, 10 µM Aβ (25-35) increased the fluorescence intensity, indicating that ROS were generated. In neurons treated with 10 µM Aβ (25-35), the relative fluorescence intensity increased approximately 5-fold to 216.7 ± 8.9 compared with the value in control neurons (42.4 ± 6.0). The Aβ (25-35)-induced increase of ROS generation was significantly inhibited by CSF (0.1, 1 and 10 ㎍/㎖) (Fig. 4) .
Effect of CSF on Aβ (25-35)-induced memory impairment
In the initial acquisition trial of the passive avoidance task, the step-through latency did not differ among the four groups (data not shown). The step-through latency of the Aβ (25-35)-treated group in the retention trial significantly decreased to 97.4 ± 9.6 s, compared with 263.2 ± 24.1 s in the control group, indicating that Aβ (25-35) impaired memory in mice. Chronically administered CSF markedly protected against the memory impairment produced by Aβ (25-35). The step-through latency in groups administered CSF was 202.5 ± 29.8, 187.0 ± 30.4 and 265.3 ± 15.8 s at doses of 10, 25 and 50 ㎎/㎏, respectively (Fig.  5) . We failed to find the dose-dependency of CSF. To determine the effect of CSF on cholinergic function, brain cholinesterase activity was measured. No significant increase of cholinesterase activity was shown in brains exposed to 15 nmol . However, chronic administration of 50 ㎎/㎏ CSF resulted in a significant reduction of cholinesterase activity showing 545.5 ± 44.7 mol/h/g brain compared with 710.5 ± 30.2 mol/h/g brain in Aβ (25-35)-treated brains (Table 1) .
DISCUSSION
Aβ (25-35) forms a β-sheet structure and induces neuronal cell death, neuritic atrophy, synaptic loss, and memory impairment, as an active partial fragment of Aβ, although it is not found in the AD brain (Maurice et al., 1996; Tohda et al., 2004) . Previously, we have reported that Aβ (25-35) caused neuronal cell death, which was blocked by treatment with (5R,10S)-(+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5,10-imine (MK-801), an NMDA antagonist, verapamil, a L-type Ca 2+ channel blocker, and N G -nitro-L -arginine methyl ester ( L -NAME), a nitric oxide synthase (NOS) inhibitor (Ban et al., 2006; Lee et al., 2005) . This result implies the involvement of NMDA-glutamate receptor activation, an increase of Ca 2+ influx and generation of ROS in Aβ (25-35)-induced neurotoxicity in cultured cortical neurons, as evidenced in other studies (Ekinci et al., 2000; Gray and Patel, 1995; Ueda et al., 1997 ] i . The ROS-induced membrane damage causes further Ca 2+ influx and resultantly accentuated Ca 2+ influx in turn will induce the generation of further ROS (Cotman et al., 1992) . CSF has been proven to be rich in antioxidant constituents such as flavonoids and vitamin C (Hamauz et al., 2005) Therefore, it also can be suggested that the CSF could inhibit the delayed [Ca
2+
] i increase through suppression of ROS generation, and resultantly ameliorated Aβ (25-35)-induced neuronal death.
Many researchers have demonstrated that Aβ triggers apoptotic degeneration in in vitro neuronal experiments (Ekinci et al., 1999; Yan et al., 1999) . In the present work, cultured cortical neurons exposed to Aβ (25-35) for 36 h showed increased chromatin condensation, a typical feature of apoptotic cell death, which was reduced by CSF. Activation of caspases after increased [Ca 2+ ] i signaling and ROS generation, or inflammatory responses in Aβ-stimulated neurons have been proposed to play pivotal roles in apoptosis (Costa et al., 2010; Gasparini et al., 2004) . We have also demonstrated that an increase of caspase-3 activity in Aβ (25-35)-treated cultured cortical neurons is correlated with the increase of [Ca 2+ ] i , ROS generation and neuronal apoptotic death (Ban et al., 2006; Lee et al., 2005) . In the present study, CSF might inhibit caspase activity to reduce Aβ (25-35)-induced neuronal apoptosis. The molecular mechanism for the prevention of neuronal apoptosis by CSF should be further clarified.
I.c.v. injection of Aβ (25-35) into experimental rodents induces memory impairment in different behavioral paradigms, including spontaneous alternation, the water maze, and passive avoidance (Maurice et al., 1996; Um et al., 2006) . Memory impairment in the passive avoidance test was also confirmed in mice 7 days after the i.c.v. injection of in the present work. Chronic treatment with CSF effectively protected the mice against Aβ (25-35)-induced memory deficit. This result was consistent with its protective effect on Aβ (25-35)-induced neurotoxicity in vitro. Aβ accumulation associated with cognitive impairment in AD is accompanied by an increase in cholinesterase activity (Maurice et al., 1996) . To slow the progression of AD and improve cognitive function, it was proposed to restore the cholinergic balance through inhibition of acetylcholine breakdown by cholinesterase (Francis et al., 1999; van Marum, 2008) . Cholinesterase inhibitors such as tacrine and donepezil have been developed for the treatment of cognitive loss in AD based on the cholinergic deficits hypothesis (van Marum, 2008) . Although a significant increase of cholinesterase activity was not produced by , it was inhibited by CSF (50 ㎎/㎏) in Aβ (25-35)-treated mice brain in the present study. This result suggests that CSF may increase cholinergic activity and be able to treat memory impairment in AD.
On the other hand, elevated levels of Aβ induce oxidative stress, increasing the appearance of ROS such as superoxide and NO and subsequently producing ONOO − by a rapid interaction, could mediate the damage seen in AD (Kontush, 2001; Smith et al., 1997) . A scavenger of ONOO − and antioxidants such as α-tocopherol protect against learning and memory deficits induced by Aβ (Alkam et al., 2007; Yamada et al., 1999) . In the present study, 10 µM Aβ (25-35) significantly increased the ROS level in cultured neurons, and this was inhibited by CSF. In addition, CSF contains flavonoids as one of the main phytochemical constituents, which are effective in preventing free radical-caused oxidative damage (Zhou et al., 2007; Zhang et al., 2009 ). Therefore, it is possible that the favorable effect of CSF on Aβ (25-35)-induced cognitive deficits can be attributed to the inhibition of ROS generation. It has been reported that aqueous extract of CSF inhibited memory deficit induced by the intrahippocampal injection of Aβ (1-40) in mice through inhibition of cytokine expression and ROS generation (Jung and Lee, 2004) . In their experiments, delayed memory impairment was produced through 10 weeks by injection of very low level of Aβ (1-40) (10 µM, 0.5 ㎕), and 284 ㎎/㎏ of CSF, which was more than 5 times higher than the highest dosage of 50 ㎎/㎏ used in the present study, was daily administered for 8 weeks. It was not until 4 weeks that the water extract of CSF revealed the inhibition of Aβ (1-40)-induced memory deficit in mice. We used an ethanol extract of CSF for 1 week to produce antidementia. These results may explain that there are considerable differences of active components between water and ethanol extract of CSF. The present results demonstrated a novel pharmacological activity, a protective effect on Aβ-induced neurotoxicity in cultured neurons, of an ethanol extract of CSF.
In conclusion, this study demonstrated that an ethanol extract of CSF protected against Aβ (25-35)-induced neuronal damage in cultured rat cortical neurons and memory impairment in mice.
These results may explain the inhibitory action of CSF on the progression of AD. Further studies should determine the specific components of CSF that are responsible for preventing the neuronal damage. 
